Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.54%)
AUD 0.06
(-1.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.3 Million AUD | 74.92% |
| 2022 | -21.14 Million AUD | -61.91% |
| 2021 | -13.06 Million AUD | 32.67% |
| 2020 | -19.4 Million AUD | 39.9% |
| 2019 | -32.28 Million AUD | -173.29% |
| 2018 | -11.81 Million AUD | -63.37% |
| 2017 | -7.23 Million AUD | -2945.28% |
| 2016 | 254.13 Thousand AUD | -95.65% |
| 2015 | 5.84 Million AUD | 250.23% |
| 2014 | 1.66 Million AUD | 121.16% |
| 2013 | -7.88 Million AUD | 66.66% |
| 2012 | -23.64 Million AUD | -56.73% |
| 2011 | -15.08 Million AUD | 35.16% |
| 2010 | -23.27 Million AUD | 25.63% |
| 2009 | -31.29 Million AUD | -10.43% |
| 2008 | -28.33 Million AUD | 32.83% |
| 2007 | -42.18 Million AUD | -33.08% |
| 2006 | -31.69 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -11.5 Million AUD | 29.7% |
| 2024 Q1 | -2.54 Million AUD | 51.97% |
| 2024 Q2 | -12.75 Million AUD | -400.74% |
| 2023 Q1 | -15.56 Million AUD | 26.41% |
| 2023 Q4 | -5.3 Million AUD | 55.28% |
| 2023 FY | -5.3 Million AUD | 74.92% |
| 2023 Q2 | -11.37 Million AUD | 26.91% |
| 2023 Q3 | -11.86 Million AUD | -4.26% |
| 2022 Q2 | -26.04 Million AUD | -424.76% |
| 2022 FY | -21.14 Million AUD | -61.91% |
| 2022 Q1 | -4.96 Million AUD | 62.0% |
| 2022 Q3 | -21.83 Million AUD | 16.17% |
| 2022 Q4 | -21.14 Million AUD | 3.14% |
| 2021 FY | -13.06 Million AUD | 32.67% |
| 2021 Q4 | -13.06 Million AUD | -0.47% |
| 2021 Q1 | -18.01 Million AUD | 7.15% |
| 2021 Q2 | -16.31 Million AUD | 9.45% |
| 2021 Q3 | -13 Million AUD | 20.3% |
| 2020 Q4 | -19.4 Million AUD | -3.39% |
| 2020 Q1 | -23.2 Million AUD | 23.25% |
| 2020 Q2 | -21.69 Million AUD | 6.49% |
| 2020 FY | -19.4 Million AUD | 39.9% |
| 2020 Q3 | -18.76 Million AUD | 13.5% |
| 2019 Q3 | -34.48 Million AUD | 31.78% |
| 2019 FY | -32.28 Million AUD | -173.29% |
| 2019 Q2 | -50.55 Million AUD | 2.59% |
| 2019 Q1 | -51.89 Million AUD | -339.91% |
| 2019 Q4 | -30.22 Million AUD | 12.34% |
| 2018 Q4 | -11.79 Million AUD | -49.9% |
| 2018 Q1 | -5.87 Million AUD | 18.69% |
| 2018 FY | -11.81 Million AUD | -63.37% |
| 2018 Q2 | -7.74 Million AUD | -31.81% |
| 2018 Q3 | -7.87 Million AUD | -1.56% |
| 2017 Q2 | -663.96 Thousand AUD | -139.1% |
| 2017 Q3 | -915.62 Thousand AUD | -37.9% |
| 2017 Q4 | -7.23 Million AUD | -689.72% |
| 2017 FY | -7.23 Million AUD | -2945.28% |
| 2017 Q1 | 1.69 Million AUD | 568.2% |
| 2016 Q1 | 7.89 Million AUD | 35.13% |
| 2016 FY | 254.13 Thousand AUD | -95.65% |
| 2016 Q4 | 254.13 Thousand AUD | 110.35% |
| 2016 Q3 | -2.45 Million AUD | -137.5% |
| 2016 Q2 | 6.54 Million AUD | -17.08% |
| 2015 Q2 | 8.18 Million AUD | 88.4% |
| 2015 Q3 | 3.29 Million AUD | -59.71% |
| 2015 Q1 | 4.34 Million AUD | 160.32% |
| 2015 Q4 | 5.84 Million AUD | 77.26% |
| 2015 FY | 5.84 Million AUD | 250.23% |
| 2014 FY | 1.66 Million AUD | 121.16% |
| 2014 Q3 | -3.47 Million AUD | -527.17% |
| 2014 Q1 | -3.7 Million AUD | 53.06% |
| 2014 Q4 | 1.66 Million AUD | 147.97% |
| 2014 Q2 | -554.49 Thousand AUD | 85.02% |
| 2013 Q4 | -7.88 Million AUD | 45.79% |
| 2013 Q2 | -17.71 Million AUD | 9.88% |
| 2013 Q1 | -19.65 Million AUD | 16.9% |
| 2013 FY | -7.88 Million AUD | 66.66% |
| 2013 Q3 | -14.54 Million AUD | 17.89% |
| 2012 Q4 | -23.64 Million AUD | -71.6% |
| 2012 Q3 | -13.78 Million AUD | 3.8% |
| 2012 Q2 | -14.32 Million AUD | 0.0% |
| 2012 FY | -23.64 Million AUD | -56.73% |
| 2011 Q3 | -18.81 Million AUD | -7.59% |
| 2011 Q2 | -17.48 Million AUD | 0.0% |
| 2011 Q4 | -15.08 Million AUD | 19.81% |
| 2011 FY | -15.08 Million AUD | 35.16% |
| 2010 Q4 | -23.27 Million AUD | 6.85% |
| 2010 Q3 | -24.98 Million AUD | 8.03% |
| 2010 FY | -23.27 Million AUD | 25.63% |
| 2010 Q2 | -27.16 Million AUD | 0.0% |
| 2009 Q2 | -22.16 Million AUD | 0.0% |
| 2009 FY | -31.29 Million AUD | -10.43% |
| 2009 Q4 | -31.29 Million AUD | 0.0% |
| 2008 FY | -28.33 Million AUD | 32.83% |
| 2008 Q4 | -28.33 Million AUD | 0.0% |
| 2008 Q2 | -35.81 Million AUD | 0.0% |
| 2007 Q2 | -22.24 Million AUD | 0.0% |
| 2007 FY | -42.18 Million AUD | -33.08% |
| 2007 Q4 | -36.99 Million AUD | 0.0% |
| 2006 FY | -31.69 Million AUD | 0.0% |
| 2006 Q4 | -30.27 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 79.188% |
| Adherium Limited | -6.1 Million AUD | 13.112% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -41.546% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -47.196% |
| Anteris Technologies Ltd | -28.49 Million AUD | 81.389% |
| Control Bionics Limited | -19.02 Thousand AUD | -27783.214% |
| CardieX Limited | 2.74 Million AUD | 293.129% |
| Compumedics Limited | 5.08 Million AUD | 204.265% |
| Cochlear Limited | -269.9 Million AUD | 98.035% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 859.234% |
| Cyclopharm Limited | -7.49 Million AUD | 29.273% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 66.22% |
| Nova Eye Medical Limited | -2.8 Million AUD | -89.291% |
| HeraMED Limited | -799.34 Thousand AUD | -563.534% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 136.622% |
| ImpediMed Limited | -23.48 Million AUD | 77.419% |
| InhaleRx Limited | -155.54 Thousand AUD | -3309.932% |
| LBT Innovations Limited | -604 Thousand AUD | -778.137% |
| Micro-X Limited | 826.99 Thousand AUD | 741.348% |
| Neurotech International Limited | -2.11 Million AUD | -151.315% |
| OncoSil Medical Limited | -4.43 Million AUD | -19.708% |
| PolyNovo Limited | -30.52 Million AUD | 82.625% |
| Respiri Limited | 413.68 Thousand AUD | 1382.109% |
| SomnoMed Limited | -15.16 Million AUD | 65.02% |
| Uscom Limited | -1.53 Million AUD | -246.52% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -29.905% |